{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:36:24Z","timestamp":1786116984007,"version":"build-2736575974"},"reference-count":157,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In recent years, the novel coronavirus infectious disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has led to over 670 million infections and nearly 7 million deaths worldwide. The global pandemic of COVID-19 has precipitated a significant public health crisis. The prevalence of liver function abnormalities associated with SARS-CoV-2 is as high as 53% among healthy individuals or patients with autoimmune hepatitis (AIH) and shows a positive correlation with disease severity; moreover, specific adaptive immune responses can influence the trajectory and outcomes of COVID-19. For instance, SARS-CoV-2 may impact autoimmunity through mechanisms such as excessive stimulation of immune responses and molecular mimicry, particularly in genetically predisposed individuals. Currently, the overall mutational trend of SARS-CoV-2 indicates heightened infectivity and immune evasion capabilities. Consequently, vaccination remains crucial for universal protection against this disease. Nevertheless, alongside the widespread implementation of vaccination programs globally, an increasing number of cases have been documented where COVID-19 vaccination appears to trigger new-onset autoimmune hepatitis; yet definitive evidence is still pending elucidation regarding causality. In this review, we analyse the clinical-immunological characteristics, risks associated with severe disease progression, and prognosis for AIH patients infected with SARS-CoV-2; discuss the detrimental effects exerted by SARS-CoV-2 on hepatic function; summarise the mechanisms and attributes leading to new-onset AIH; as well as provide insights into how vaccination may interfere with autoimmunity processes. We continue to underscore the significance of vaccination while aiming to enhance awareness concerning potential risks associated with it\u2014this could facilitate better management strategies for autoimmune diseases along with appropriate adjustments in vaccination protocols. Although the precise triggering mechanism linking COVID-19-related events to AIH remains unclear, existing evidence suggests that this relationship is far from coincidental.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1510770","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T01:44:08Z","timestamp":1738287848000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations"],"prefix":"10.3389","volume":"16","author":[{"given":"Chaojie","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjing","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2045853","DOI":"10.1080\/21645515.2022.2045853","article-title":"COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges","volume":"18","author":"Dhama","year":"2022","journal-title":"Hum Vaccines Immunother"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03470-x","article-title":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England","volume":"593","author":"Volz","year":"2021","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03402-9","article-title":"Detection of a SARS-CoV-2 variant of concern in South Africa","volume":"592","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh2644","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume":"372","author":"Faria","year":"2021","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3350\/cmh.2020.0189","article-title":"Recent updates on the management of autoimmune hepatitis","volume":"27","author":"Komori","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.008","article-title":"Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy","volume":"73","author":"Di Giorgio","year":"2020","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ueg2.12100","article-title":"Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey","volume":"9","author":"Zecher","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.08.035","article-title":"Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium","volume":"74","author":"Verhelst","year":"2021","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1557","article-title":"Coronavirus disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients","volume":"4","author":"Gerussi","year":"2020","journal-title":"Hepatol Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15121","article-title":"Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis","volume":"42","author":"Efe","year":"2022","journal-title":"Liver Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"SARS-CoV-2 infection in patients with autoimmune hepatitis","volume":"74","author":"Marjot","year":"2021","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25756","article-title":"Coronaviruses and immunosuppressed patients: the facts during the third epidemic","volume":"26","author":"D\u2019Antiga","year":"2020","journal-title":"Liver Transpl"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31797","article-title":"Outcome of COVID-19 in patients with autoimmune hepatitis: an international multicentre study","volume":"73","author":"Efe","year":"2021","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","author":"Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100169","DOI":"10.1016\/j.jhepr.2020.100169","article-title":"Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1719996","article-title":"The continuous rediscovery and the benefit\u2013risk ratio of thioguanine, a comprehensive review","volume":"16","author":"Bayoumy","year":"2020","journal-title":"Expert OpinDrug Metab Toxicol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.002","article-title":"Management of patients with autoimmune liver disease during COVID-19 pandemic","volume":"73","author":"Lleo","year":"2020","journal-title":"J Hepatol"},{"key":"B20","volume-title":"Coronavirus disease 2019 (COVID-19) treatment guidelines","year":"2020"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25819","article-title":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis","volume":"92","author":"Lagunas-Rangel","year":"2020","journal-title":"J Med Virol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","article-title":"The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages","volume":"48","author":"Evavold","year":"2018","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"102506","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and autoimmune conditions at the crossroad of COVID-19","volume":"114","author":"Rodr\u00edguez","year":"2020","journal-title":"J Autoimmun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25866","article-title":"Mathematical modelling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis","volume":"92","author":"Du","year":"2020","journal-title":"J Med Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"102592","DOI":"10.1016\/j.jaut.2020.102592","article-title":"The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 \u2014 a systematic review of the literature","volume":"117","author":"Novelli","year":"2020","journal-title":"J Autoimmun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.041","article-title":"Rotavirus and autoimmunity","volume":"81","author":"G\u00f3mez-Rial","year":"2020","journal-title":"J Infect"},{"key":"B32","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti","year":"2019","journal-title":"Viruses"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-barr\u00e9 Syndrome associated with SARS-coV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218594","article-title":"Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future","volume":"81","author":"Wang","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218520","article-title":"Transient monoarthritis and psoriatic skin lesions following COVID-19","volume":"82","author":"De Stefano","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2010472","article-title":"Immune thrombocytopenic purpura in a patient with covid-19","volume":"382","author":"Zulfiqar","year":"2020","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154886","article-title":"The intersection of COVID-19 and autoimmunity","volume":"131","author":"Knight","year":"2021","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05359-y","article-title":"High levels of anti-SSA\/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review: High levels of anti-SSA\/Ro antibodies in COVID-19","volume":"39","author":"Fujii","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02182-9","article-title":"Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients","volume":"50","author":"Zhang","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.02.006","article-title":"Primary biliary cholangitis associated with SARS-CoV-2 infection","volume":"74","author":"Bartoli","year":"2021","journal-title":"J Hepatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.autrev.2020.102695","article-title":"SARS-CoV-2, the autoimmune virus","volume":"19","author":"Halpert","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59777","article-title":"Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice","volume":"121","author":"Zhao","year":"2011","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.jhepr.2020.100094","article-title":"Features and outcome of AIH patients without elevation of IgG","volume":"2","author":"Hartl","year":"2020","journal-title":"JHEP Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.jhepr.2020.100113","article-title":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.medj.2020.04.001","article-title":"Efficacy and safety of lopinavir\/ritonavir or arbidol in adult patients with mild\/moderate COVID-19: an exploratory randomized controlled trial","volume":"1","author":"Li","year":"2020","journal-title":"Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20111","article-title":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases","volume":"39","author":"Chau","year":"2004","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/his.2018.72.issue-3","article-title":"Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection-clinicopathological and ultrastructural study","volume":"72","author":"Alsaad","year":"2018","journal-title":"Histopathology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.03.931766","article-title":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection","author":"Chai","year":"2020","journal-title":"bioRxiv"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine","volume":"68","author":"Kanduc","year":"2020","journal-title":"Immunol Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting diagnostic tests for SARS-coV-2","volume":"323","author":"Sethuraman","year":"2020","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.09.024","article-title":"Human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications","volume":"164","author":"Nagata","year":"2023","journal-title":"Gastroenterology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"102865","DOI":"10.1016\/j.autrev.2021.102865","article-title":"Autoimmunity and COVID-19 - The microbiotal connection","volume":"20","author":"Katz-Agranov","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B57","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41590-021-00900-w","article-title":"Coping with COVID","volume":"22","year":"2021","journal-title":"Nat Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.004","article-title":"Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty","volume":"75","author":"Londo\u00f1o","year":"2021","journal-title":"J Hepatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e11621","DOI":"10.1097\/MD.0000000000011621","article-title":"Autoimmune hepatitis following influenza virus vaccination: Two case reports","volume":"97","author":"Sasaki","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2019.02.007","article-title":"Development of autoimmune hepatitis after influenza vaccination; trigger or killer","volume":"43","author":"Muratori","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s13167-017-0101-y","article-title":"Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon","volume":"8","author":"Vadal\u00e0","year":"2017","journal-title":"EPMA J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab250","article-title":"Jaundice in a primary sclerosing cholangitis patient: A new cause in a new era","volume":"28","author":"Nik Muhamad Affendi","year":"2022","journal-title":"Inflammation Bowel Dis"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15224","article-title":"Autoimmune hepatitis or drug-induced autoimmune hepatitis following Covid-19 vaccination","volume":"42","author":"Fimiano","year":"2022","journal-title":"Liver Int"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32156","article-title":"Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination: A rare adverse effect","volume":"75","author":"Palla","year":"2022","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty","volume":"75","author":"Bril","year":"2021","journal-title":"J Hepatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.005","article-title":"An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injury","volume":"75","author":"Lodato","year":"2021","journal-title":"J Hepatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15350","article-title":"Autoimmune hepatitis (AIH) following coronavirus (COVID-19) vaccine-No longer exclusive to mRNA vaccine","volume":"42","author":"Shahrani","year":"2022","journal-title":"Liver Int"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.040","article-title":"SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis","volume":"77","author":"Boettler","year":"2022","journal-title":"J Hepatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"goac014","DOI":"10.1093\/gastro\/goac014","article-title":"Acute hepatitis with autoimmune features after COVID-19 vaccine: coincidence or vaccine-induced phenomenon","volume":"10","author":"Pinazo-Bandera","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e116","article-title":"Autoimmune hepatitis following vaccination for SARS-coV-2 in korea: coincidence or autoimmunity","volume":"37","author":"Kang","year":"2022","journal-title":"J Korean Med Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32269","article-title":"Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination","volume":"75","author":"Cao","year":"2022","journal-title":"Hepatology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"102745","DOI":"10.1016\/j.jaut.2021.102745","article-title":"Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up","volume":"125","author":"Avci","year":"2021","journal-title":"J Autoimmun"},{"key":"B73","doi-asserted-by":"publisher","first-page":"102741","DOI":"10.1016\/j.jaut.2021.102741","article-title":"Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence","volume":"125","author":"Garrido","year":"2021","journal-title":"J Autoimmun"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.006","article-title":"New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant","volume":"76","author":"Zhou","year":"2022","journal-title":"J Hepatol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"102706","DOI":"10.1016\/j.jaut.2021.102706","article-title":"Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity","volume":"123","author":"Ghielmetti","year":"2021","journal-title":"J Autoimmun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.841506","article-title":"The mRNA COVID-19 vaccine \u2013 A rare trigger of autoimmune hepatitis","volume":"75","author":"McShane","year":"2021","journal-title":"J Hepatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.014","article-title":"Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine","volume":"75","author":"Clayton-Chubb","year":"2021","journal-title":"J Hepatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.009","article-title":"Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association","volume":"75","author":"Tan","year":"2021","journal-title":"J Hepatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.038","article-title":"Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality","volume":"75","author":"Rocco","year":"2021","journal-title":"J Hepatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.09.031","article-title":"Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed","volume":"76","author":"Zin Tun","year":"2022","journal-title":"J Hepatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.029","article-title":"Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination","volume":"77","author":"Lee","year":"2022","journal-title":"J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16491","article-title":"Drug-induced liver injury after COVID-19 vaccine","volume":"13","author":"Mann","year":"2021","journal-title":"Cureus"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000811","article-title":"Autoimmune hepatitis triggered by COVID-19 vaccine: the first case from inactivated vaccine","volume":"9","author":"Mekritthikrai","year":"2022","journal-title":"ACG Case Rep J"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-coV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-coV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"105592","DOI":"10.1016\/j.micpath.2022.105592","article-title":"Characterization of proteome wide antigenic epitopes to design proteins specific and proteome-wide ensemble vaccines against heartland virus using structural vaccinology and immune simulation approaches","volume":"168","author":"Suleman","year":"2022","journal-title":"Microb Pathog"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03181-w","article-title":"Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukaemia virus: a molecular dynamics and immune simulation approaches","volume":"71","author":"Samad","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B91","doi-asserted-by":"publisher","first-page":"103070","DOI":"10.1016\/j.jaut.2023.103070","article-title":"Molecular mimicry and autoimmunity in the time of COVID-19","volume":"139","author":"Rojas","year":"2023","journal-title":"J Autoimmun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.05.014","article-title":"On vaccine\u2019s adjuvants and autoimmunity: Current evidence and future perspectives","volume":"14","author":"Pellegrino","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3109\/08830181003746304","article-title":"Could autoimmunity be induced by vaccination","volume":"29","author":"Salemi","year":"2010","journal-title":"Int Rev Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0316-1","article-title":"The activation of bystander CD8+ T cells and their roles in viral infection","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"B97","doi-asserted-by":"publisher","first-page":"102301","DOI":"10.1016\/j.jaut.2019.06.012","article-title":"Bystander activation and autoimmunity","volume":"103","author":"Pacheco","year":"2019","journal-title":"J Autoimmun"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200940017","article-title":"Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoid","volume":"40","author":"Di Genova","year":"2010","journal-title":"Eur J Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040466","article-title":"Bystander activation of CD4+ T cells","volume":"40","author":"Boyman","year":"2010","journal-title":"Eur J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3255","article-title":"Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific","volume":"107","author":"Di Genova","year":"2006","journal-title":"Blood"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177365","article-title":"Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant","volume":"12","author":"van Aalst","year":"2017","journal-title":"PloS One"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01206-4","article-title":"Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma","volume":"27","author":"Hu","year":"2021","journal-title":"Nat Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(96)80012-4","article-title":"Epitope spreading","volume":"8","author":"Vanderlugt","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.06.005","article-title":"Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model","volume":"37","author":"Hintermann","year":"2011","journal-title":"J Autoimmun"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac105","article-title":"Autoantibodies and COVID-19: rediscovering nonspecific polyclonal B-cell activation","volume":"226","author":"Cimolai","year":"2022","journal-title":"J Infect Dis"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.1997.tb03594.x","article-title":"Anti-smooth muscle antibody in clinical human and experimental animal Mycoplasma pneumoniae infection","volume":"82","author":"Cimolai","year":"1997","journal-title":"J Appl Microbiol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"108665","DOI":"10.1016\/j.clim.2021.108665","article-title":"Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \u201cpotential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"224","author":"Talotta","year":"2021","journal-title":"Clin Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"108721","DOI":"10.1016\/j.clim.2021.108721","article-title":"Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon","volume":"226","author":"Akinosoglou","year":"2021","journal-title":"Clin Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.016","article-title":"A global effort to define the human genetics of protective immunity to SARS-coV-2 infection","volume":"181","author":"Casanova","year":"2020","journal-title":"Cell"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27157","article-title":"Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network","volume":"60","author":"Russo","year":"2014","journal-title":"Hepatology"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.05.027","article-title":"Drug-induced autoimmune hepatitis: response to corticosteroids and lack of relapse after cessation of steroids","volume":"15","author":"Bj\u00f6rnsson","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2019.11.004","article-title":"Pregnancy and autoimmune diseases","volume":"64","author":"Somers","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.berh.2016.05.002","article-title":"Pregnancy and autoimmune connective tissue diseases","volume":"30","author":"Marder","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00245-9","article-title":"Severe autoimmune hepatitis first presenting in the early postpartum period","volume":"2","author":"Samuel","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.020","article-title":"Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics","volume":"79","author":"Uzun","year":"2023","journal-title":"J Hepatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"102906","DOI":"10.1016\/j.jaut.2022.102906","article-title":"SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis","volume":"132","author":"Efe","year":"2022","journal-title":"J Autoimmun"},{"key":"B120","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/liv.15368","article-title":"Analysis of the humoral and cellular response after the third COVID-19 vaccination in patients with autoimmune hepatitis","volume":"43","author":"Hartl","year":"2023","journal-title":"Liver Int"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"B123","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai","year":"2022","journal-title":"Cell"},{"key":"B124","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cgh.2021.09.003","article-title":"SARS-coV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients","volume":"20","author":"Ruether","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1177\/15353702231181343","article-title":"Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19","volume":"248","author":"Ara\u00fajo","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2024.0029","article-title":"Association of interleukin-6 (rs1800795) and interleukin-10 (rs1800896) genetic polymorphisms with the outcome of COVID-19 infection: A single centre study","volume":"37","author":"El-Bendary","year":"2024","journal-title":"Viral Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.17717","article-title":"Influence of IL-6 rs1800795 and IL-8 rs2227306 polymorphisms on COVID-19 outcome","volume":"17","author":"Ghazy","year":"2023","journal-title":"J Infect Dev Ctries"},{"key":"B128","doi-asserted-by":"publisher","first-page":"156445","DOI":"10.1016\/j.cyto.2023.156445","article-title":"Impact of IL-6 rs1800795 and IL-17A rs2275913 gene polymorphisms on the COVID-19 prognosis and susceptibility in a sample of Iranian patients","volume":"174","author":"Khafaei","year":"2024","journal-title":"Cytokine"},{"key":"B129","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/pathogens13100915","article-title":"Interleukin-1 Beta rs16944 and rs1143634 and Interleukin-6 Receptor rs12083537 Single Nucleotide Polymorphisms as Potential Predictors of COVID-19 Severity","volume":"13","author":"Ahmed","year":"2024","journal-title":"Pathogens"},{"key":"B130","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12920-024-01911-w","article-title":"The Interleukin-6 gene variants may protect against SARS-CoV-2 infection and the severity of COVID-19: a case-control study in a Moroccan population","volume":"17","author":"Noureddine","year":"2024","journal-title":"BMC Med Genomics"},{"key":"B131","doi-asserted-by":"publisher","first-page":"3946320241279893","DOI":"10.1177\/03946320241279893","article-title":"Implication of IL-12A, IL-12B, IL-6, and TNF single-nucleotide polymorphisms in severity and susceptibility to COVID-19","volume":"38","author":"Benmansour","year":"2024","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i18.2768","article-title":"Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"11","author":"Fan","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0012.7202","article-title":"Association of interleukin-6 and interleukin-1 family gene polymorphisms in autoimmune hepatitis","volume":"17","author":"Yousefi","year":"2018","journal-title":"Ann Hepatol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018408","article-title":"Interleukin-6 gene polymorphisms and susceptibility to liver diseases: A meta-analysis","volume":"98","author":"Wang","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B135","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11033-024-09569-4","article-title":"Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia","volume":"51","author":"Pokhylko","year":"2024","journal-title":"Mol Biol Rep"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae031","article-title":"Interleukin-1 receptor antagonist gene (IL1RN) variants modulate the cytokine release syndrome and mortality of COVID-19","volume":"229","author":"Attur","year":"2024","journal-title":"J Infect Dis"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis","volume":"30","author":"Cookson","year":"1999","journal-title":"Hepatology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-018-9867-4","article-title":"Association of TNF-\u03b1-308 polymorphism with susceptibility to autoimmune hepatitis in Tunisians","volume":"56","author":"Chaouali","year":"2018","journal-title":"Biochem Genet"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.vacun.2023.04.002","article-title":"The polymorphisms of TNF-\u03b1 related-gene and antibody production following third dose of COVID-19 vaccination: A pilot study","author":"Liana","year":"2023","journal-title":"Vacunas"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2020.1851709","article-title":"Association of TNF-\u03b1 G-308 a promoter polymorphism with the course and outcome of COVID-19 patients","volume":"51","author":"Saleh","year":"2022","journal-title":"Immunol Invest"},{"key":"B141","doi-asserted-by":"publisher","first-page":"11044","DOI":"10.3389\/bjbs.2023.11044","article-title":"Relevance of HLA-DP\/DQ and INF-\u03bb4 polymorphisms to COVID-19 outcomes","volume":"80","author":"Ghazy","year":"2023","journal-title":"Br J BioMed Sci"},{"key":"B142","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12916-020-01673-z","article-title":"New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis","volume":"18","author":"Hou","year":"2020","journal-title":"BMC Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31893","article-title":"Human leukocyte antigen profile predicts severity of autoimmune liver disease in children of european ancestry","volume":"74","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2021.04.011","article-title":"Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia","volume":"560","author":"Naemi","year":"2021","journal-title":"Virology"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01229.x","article-title":"Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2","volume":"94","author":"Bittencourt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune hepatitis, HLA and extended haplotypes","volume":"10","author":"Oliveira","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B147","doi-asserted-by":"publisher","first-page":"100926","DOI":"10.1016\/j.jhepr.2023.100926","article-title":"Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1","volume":"6","author":"Li","year":"2023","journal-title":"JHEP Rep"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.3390\/biomedicines11102848","article-title":"Investigating acute hepatitis after SARS-coV-2 vaccination or infection: A genetic case series","volume":"11","author":"Bernasconi","year":"2023","journal-title":"Biomedicines"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.11.032","article-title":"An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis","volume":"80","author":"Snijders","year":"2024","journal-title":"J Hepatol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"100601","DOI":"10.1016\/j.jhepr.2022.100601","article-title":"Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis","volume":"4","author":"Dalekos","year":"2022","journal-title":"JHEP Rep"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00078-3","article-title":"Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe","volume":"3","author":"Mehta","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2001919","DOI":"10.1183\/13993003.01919-2020","article-title":"JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk","volume":"56","author":"Mehta","year":"2020","journal-title":"Eur Respir J"},{"key":"B155","doi-asserted-by":"publisher","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antiviral Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2024.10053\/2023","article-title":"Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis","volume":"116","author":"Tian","year":"2024","journal-title":"Rev Esp Enferm Dig"},{"key":"B157","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/v15030678","article-title":"Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients","volume":"15","author":"Lee","year":"2023","journal-title":"Viruses"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1950438","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1510770\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:06:40Z","timestamp":1786021600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1510770\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":157,"alternative-id":["10.3389\/fimmu.2025.1510770"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1510770","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"1510770"}}